← Leaderboards
Eric H Kim
Washington University
$1,822,867
Attributed
$3,994,569
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$3,994,569 · 2
By mechanism
R01$3,994,569 · 2
Top collaborators
- Joseph Edward Ippolito7 shared
- Michael Hiroshi Johnson2 shared
Most similar at Washington University
Same institution · by research overlap
- Sheng-Kwei Song$14,973,079
- Yong Wang$8,889,709
- Randall J Bateman$192,965,895
- Dorothy Anne Cross$5,584,847
- Tammie Lee Smith Benzinger$27,265,928
Others in their field
Other Rising Stars on “Pathology”
- Gary Mays · Axle Informatics, Llc$59,047,077
- Mari Ostendorf · University Of Washington$51,931,230
- Thomas K Karikari · Wake Forest University Health Sciences$14,340,584
- Hill Georgette · Integrated Laboratory Systems, Llc$10,800,000
- Joon Sup Lee · Emory University$10,751,414
- Jennifer Lee O'Brien · University Of South Florida$10,506,386
Research focus
PathologySensitivity And SpecificityImageNomogramsProstatectomyRisk StratificationClinical TranslationHistologyMalignant Neoplasm Of ProstateMalignant NeoplasmsProspectiveProstateRadical ProstatectomyBiological MarkersBiopsyArtificial Intelligence AlgorithmClinical RiskDiffusionCohortMagnetic Resonance ImagingBenignDiagnosisPatient SubsetsTissues
Grant awards (7)
Identifying lethal prostate cancer at diagnosis with advanced proteoglycomic, radiomic, and genomic approaches$592,905
R01 · FY2025 · CA
Diffusion Histology Imaging: A Clinical Tool to Non-Invasively Diagnose and Manage Prostate Cancer$512,247
R01 · FY2025 · CA
Identifying lethal prostate cancer at diagnosis with advanced proteoglycomic, radiomic, and genomic approaches$592,860
R01 · FY2024 · CA
Diffusion Histology Imaging: A Clinical Tool to Non-Invasively Diagnose and Manage Prostate Cancer$534,257
R01 · FY2024 · CA
Identifying lethal prostate cancer at diagnosis with advanced proteoglycomic, radiomic, and genomic approaches$637,936
R01 · FY2023 · CA
Diffusion Histology Imaging: A Clinical Tool to Non-Invasively Diagnose and Manage Prostate Cancer$581,203
R01 · FY2023 · CA · contact PI
Diffusion Histology Imaging: A Clinical Tool to Non-Invasively Diagnose and Manage Prostate Cancer$543,161
R01 · FY2022 · CA · contact PI